文献速递胃肠外科

机器人与腹腔镜远端胃切除术治疗胃癌的随机对照试验评估

Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled Trial.
PubMed 文献 · Ann Surg · 2021-01-01

改良意向治疗分析纳入283例(RDG组141例,LDG组142例),结果显示RDG组术后恢复更快、炎症反应更轻、术后并发症发生率更低(9.2% vs 17.6%,P=0.039),且淋巴结清扫质量更高。

要点

  • RDG组术后并发症发生率显著低于LDG组(9.2% vs 17.6%,P=0.039)。
  • RDG组胃外淋巴结清扫数量更多(17.6±5.8 vs 15.8±6.6,P=0.018),不符合率更低(7.7% vs 16.9%,P=0.006)。
  • RDG组辅助化疗启动更早(中位术后天数28 vs 32,P=0.003)。

核心结论

  • RDG与更低的并发症发生率、更快的恢复、更轻的炎症反应及更优的淋巴结清扫相关。
  • RDG组术后恢复更快,使辅助化疗能够更早启动。
  • 结果为RDG在胃癌患者中的应用提供了证据。

研究设计与样本

  • 改良意向治疗分析纳入283例患者(RDG组141例,LDG组142例)。

主要发现

  • RDG组术后并发症发生率为9.2%,LDG组为17.6%(P=0.039)。
  • RDG组胃外淋巴结获取数量为17.6±5.8枚,LDG组为15.8±6.6枚(P=0.018)。
  • RDG组淋巴结清扫不符合率为7.7%,LDG组为16.9%(P=0.006)。
  • RDG组辅助化疗启动中位术后天数为28天(24-32),LDG组为32天(26-42)(P=0.003)。
  • RDG组总住院费用高于LDG组,但直接成本低于LDG组(均P<0.001)。

临床怎么用

  • 对于cT1-4a、N0/+胃癌患者,RDG可考虑作为LDG的替代术式,以降低并发症并提高淋巴结清扫质量。
  • RDG术后恢复更快,有助于尽早启动辅助化疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the short-term outcomes of patients with GC who received RDG or LDG. SUMMARY BACKGROUND DATA: Despite the increasing use of RDG in patients with GC, its safety and efficacy compared to those of LDG have not been elucidated in a randomized controlled trial. METHODS: Three hundred patients with cT1-4a and N0/+ between September 2017 and January 2020 were enrolled in this randomized controlled trial at a high-volume hospital in China. The short-term outcomes were compared between the groups. RESULTS: The modified intention-to-treat analysis included data from 283 patients (RDG group: n = 141) and (LDG group: n = 142). Patients in the RDG group exhibited faster postoperative recovery, milder inflammatory responses, and reduced postoperative morbidity (9.2% vs 17.6%, respectively, P = 0.039). Higher extraperigastric lymph nodes (LNs) were retrieved in the RDG group (17.6 ± 5.8 vs 15.8 ± 6.6, P = 0.018) with lower noncompliance rate (7.7% vs 16.9%, respectively, P = 0.006). Additionally, patients in the RDG group were more likely to initiate adjuvant chemotherapy earlier [median (interquartile range) postoperative days: 28 (24-32) vs 32 (26-42), P = 0.003]. Although total hospital costs were higher in the robotic group than in the laparoscopic group, the direct cost was lower for RDG than for LDG (all P < 0.001). CONCLUSIONS: RDG is associated with a lower morbidity rate, faster recovery, milder inflammatory responses, and improved lymphadenectomy. Additionally, faster postoperative recovery in the RDG group enables early initiation of adjuvant chemotherapy. Our results provide evidence for the application of RDG in patients with GC.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Lu J, Zheng CH, Xu BB, et al. Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled Trial. Ann Surg. 2021. PMID: 32889876. doi:10.1097/SLA.0000000000004466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。